Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. (Q44124436)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209992%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209992%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209992%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Maria Friberg

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209992%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Ronald Jennings

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209992%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Marwan Alsarraj

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209992%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Sophie Dessureault

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209992%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Alan Cantor

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209992%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Martine Extermann

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209992%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Andrew L Mellor

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209992%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Scott J Antonia

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209992%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209992%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209992%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

101

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209992%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209992%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

151-155

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209992%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10645

21 January 2018

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10645

21 January 2018

An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillanc

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10645

21 January 2018

Antigenic Cancer Cells Grow Progressively in Immune Hosts without Evidence for T Cell Exhaustion or Systemic Anergy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10645

21 January 2018

Autoaggression and tumor rejection: it takes more than self-specific T-cell activation.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10645

21 January 2018

Self Antigens Expressed by Solid Tumors Do Not Efficiently Stimulate Naive or Activated T Cells: Implications for Immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10645

21 January 2018

Immune surveillance against a solid tumor fails because of immunological ignorance

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10645

21 January 2018

Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10645

21 January 2018

Cutting Edge: The Tumor Counterattack Hypothesis Revisited: Colon Cancer Cells Do Not Induce T Cell Apoptosis Via the Fas (CD95, APO-1) Pathway

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10645

21 January 2018

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10645

21 January 2018

Inhibition of T cell proliferation by macrophage tryptophan catabolism

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10645

21 January 2018

Prevention of allogeneic fetal rejection by tryptophan catabolism

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10645

21 January 2018

Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10645

21 January 2018

Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10645

21 January 2018

Establishment of a cloned line of Lewis lung carcinoma cells adapted to cell culture

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10645

21 January 2018

Regulation of prostaglandin synthesis and cell adhesion by a tryptophan catabolizing enzyme

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10645

21 January 2018

The host-tumor immune conflict: from immunosuppression to resistance and destruction

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10645

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44124436&oldid=2106835133"